Featured & Most Booked
Hepatitis B Vaccine
Hepatitis B is a viral infection that attacks the liver and can cause both acute illness and life-long chronic liver disease, leading to cirrhosis and hepatocellular carcinoma (liver cancer). It is transmitted through direct contact with infected blood, semen, and other body fluids—such as through medical or dental procedures with non-sterile equipment, emergency healthcare abroad, tattooing, body piercing, unsterile needle use, and sexual contact. The Hepatitis B vaccine (such as Engerix B) is a recombinant DNA vaccine containing hepatitis B surface antigen (HBsAg). A standard course involves 3 doses (at 0, 1, and 6 months) or an accelerated schedule (0, 7, 21 days with a 12-month booster) for last-minute travellers needing rapid protection.
Japanese Encephalitis Vaccine
Japanese Encephalitis (JE) is a serious viral brain infection spread by Culex mosquitoes that breed in flooded rice paddies and stagnant water in rural and agricultural regions across Southeast Asia, the Pacific, China, and the Indian subcontinent. While many infections are mild, about 1 in 250 cases progresses to severe encephalitis with high fever, seizures, paralysis, coma, and a 30% mortality rate, with permanent neurological deficits in half of survivors. The Japanese Encephalitis vaccine (Ixiaro) is an inactivated, cell-culture derived vaccine. The schedule consists of two doses given 28 days apart (or a rapid schedule 7 days apart for adults aged 18–65) providing robust protection.
Rabies Vaccine
Rabies is an almost 100% fatal viral infection of the central nervous system transmitted through the saliva of infected mammals (primarily dogs, bats, monkeys, and cats) via bites, scratches, or licks on broken skin. Once clinical symptoms develop, rabies is virtually incurable. Pre-exposure rabies prophylaxis (such as Rabipur) involves a course of inactivated cell-culture rabies vaccines. Pre-exposure vaccination simplifies post-exposure medical management if you are bitten abroad by eliminating the need for Rabies Immunoglobulin (RIG)—a biological product that is extremely scarce and often counterfeit or unavailable in developing nations—and reducing the required post-exposure vaccine course from four doses to two.
Tick-Borne Encephalitis (TBE) Vaccine
Tick-Borne Encephalitis (TBE) is a viral infection of the central nervous system transmitted through the bites of infected ticks (Ixodes ricinus and Ixodes persulcatus) in forested, woodland, and grassy rural areas across Central, Northern, and Eastern Europe (including Germany, Austria, Switzerland, Scandinavia, the Baltics) and parts of Northern Asia. TBE often presents in two phases: an initial flu-like illness followed by neurological involvement including meningitis, encephalitis, and paralysis. Vaccination with TicoVac is the most reliable method of prevention for outdoor enthusiasts, hikers, campers, and forestry workers visiting risk regions during tick season (spring through autumn).
Travel Vaccinations
Hepatitis B Vaccine
Hepatitis B is a viral infection that attacks the liver and can cause both acute illness and life-long chronic liver disease, leading to cirrhosis and hepatocellular carcinoma (liver cancer). It is transmitted through direct contact with infected blood, semen, and other body fluids—such as through medical or dental procedures with non-sterile equipment, emergency healthcare abroad, tattooing, body piercing, unsterile needle use, and sexual contact. The Hepatitis B vaccine (such as Engerix B) is a recombinant DNA vaccine containing hepatitis B surface antigen (HBsAg). A standard course involves 3 doses (at 0, 1, and 6 months) or an accelerated schedule (0, 7, 21 days with a 12-month booster) for last-minute travellers needing rapid protection.
Japanese Encephalitis Vaccine
Japanese Encephalitis (JE) is a serious viral brain infection spread by Culex mosquitoes that breed in flooded rice paddies and stagnant water in rural and agricultural regions across Southeast Asia, the Pacific, China, and the Indian subcontinent. While many infections are mild, about 1 in 250 cases progresses to severe encephalitis with high fever, seizures, paralysis, coma, and a 30% mortality rate, with permanent neurological deficits in half of survivors. The Japanese Encephalitis vaccine (Ixiaro) is an inactivated, cell-culture derived vaccine. The schedule consists of two doses given 28 days apart (or a rapid schedule 7 days apart for adults aged 18–65) providing robust protection.
Rabies Vaccine
Rabies is an almost 100% fatal viral infection of the central nervous system transmitted through the saliva of infected mammals (primarily dogs, bats, monkeys, and cats) via bites, scratches, or licks on broken skin. Once clinical symptoms develop, rabies is virtually incurable. Pre-exposure rabies prophylaxis (such as Rabipur) involves a course of inactivated cell-culture rabies vaccines. Pre-exposure vaccination simplifies post-exposure medical management if you are bitten abroad by eliminating the need for Rabies Immunoglobulin (RIG)—a biological product that is extremely scarce and often counterfeit or unavailable in developing nations—and reducing the required post-exposure vaccine course from four doses to two.
Tick-Borne Encephalitis (TBE) Vaccine
Tick-Borne Encephalitis (TBE) is a viral infection of the central nervous system transmitted through the bites of infected ticks (Ixodes ricinus and Ixodes persulcatus) in forested, woodland, and grassy rural areas across Central, Northern, and Eastern Europe (including Germany, Austria, Switzerland, Scandinavia, the Baltics) and parts of Northern Asia. TBE often presents in two phases: an initial flu-like illness followed by neurological involvement including meningitis, encephalitis, and paralysis. Vaccination with TicoVac is the most reliable method of prevention for outdoor enthusiasts, hikers, campers, and forestry workers visiting risk regions during tick season (spring through autumn).
Typhoid Vaccine
Typhoid fever is a life-threatening bacterial infection caused by Salmonella Typhi, primarily spread through contaminated food and drinking water in areas with limited sanitation and poor hygiene standards. It is most prevalent in South Asia (India, Pakistan, Bangladesh), parts of Southeast Asia, Africa, and Central/South America. Symptoms include persistent high fever, severe headache, generalized aches, fatigue, constipation or diarrhea, and in severe cases, intestinal perforation. Vaccination is strongly recommended by the NHS and UK Travel Health guidelines for travellers visiting endemic areas, especially those visiting friends and relatives (VFR), staying in rural accommodations, or travelling for more than a few weeks. The injectable Vi polysaccharide vaccine (Typhim Vi) provides effective protection lasting 3 years.
Cholera Vaccine (Oral)
Cholera is an acute diarrhoeal disease caused by ingestion of food or water contaminated with the bacterium Vibrio cholerae. It is capable of causing rapid and severe dehydration through profuse watery diarrhea ('rice-water stools') and vomiting, which can become fatal within hours if untreated. The oral cholera vaccine (Dukoral) is a pleasant-tasting drinkable suspension containing inactivated Vibrio cholerae bacteria and recombinant cholera toxin B subunit. In addition to protecting against cholera, the B subunit cross-protects against enterotoxigenic Escherichia coli (ETEC), the leading cause of travellers' diarrhea. The vaccine is taken as 2 oral doses (for adults and children over 6) spaced 1 to 6 weeks apart.
Dengue Fever Vaccine
Dengue fever is a mosquito-borne viral infection caused by four distinct dengue virus serotypes (DENV 1–4) transmitted by daytime-biting Aedes aegypti and Aedes albopictus mosquitoes. Widely endemic in tropical and subtropical regions of Southeast Asia, the Caribbean, Central and South America, the Pacific, and Africa, dengue causes severe flu-like symptoms including sudden high fever, intense retro-orbital (behind the eye) headache, muscle and joint pain ('breakbone fever'), nausea, and rash. A second infection with a different serotype significantly increases the risk of severe dengue (dengue hemorrhagic fever). Qdenga is a modern tetravalent live-attenuated dengue vaccine approved by the UK MHRA and EMA for individuals aged 4 and older, regardless of prior dengue infection history. The schedule consists of two subcutaneous doses given 3 months apart.
Hepatitis A + B Combined (Twinrix)
Dual infection risks from both Hepatitis A (transmitted through food and water) and Hepatitis B (transmitted through blood and bodily fluids) exist in many developing and tropical travel destinations across Africa, Asia, Latin America, and Eastern Europe. The combined Hepatitis A and Hepatitis B vaccine (Twinrix) offers streamlined dual protection in a single injection, minimizing the total number of visits and injections required. The standard schedule consists of three doses administered at 0, 1, and 6 months. For travellers with imminent departure dates, an accelerated course (doses given at Day 0, Day 7, and Day 21, followed by a fourth dose at 12 months) provides rapid, reliable immunity.
Hepatitis A Vaccine
Hepatitis A is a viral liver infection transmitted via the fecal-oral route, typically by consuming food or water contaminated with the feces of an infected person, or through close physical contact. The virus is widespread in areas with poor sanitation and limited access to clean water across parts of Africa, Asia, the Middle East, and South/Central America. Symptoms include fatigue, nausea, abdominal pain, loss of appetite, dark urine, pale stools, and jaundice (yellowing of eyes and skin). The Hepatitis A vaccine (such as Havrix or Vaqta) contains inactivated hepatitis A virus that triggers high levels of neutralizing antibodies. A single initial dose provides protection for up to 1 year, and a booster dose given 6 to 12 months later extends immunity for at least 25 years.
Clinical Services
Vitamin B12 Injection
A Vitamin B12 injection is a form of vitamin B12 replacement delivered by injection. It may be used where vitamin B12 deficiency has been identified or where a healthcare professional determines that injectable replacement is appropriate. During the appointment, a qualified healthcare professional will assess your symptoms, medical history and relevant test results where available, and determine whether treatment is suitable. The type, dose and frequency of injections will depend on the underlying cause of deficiency and the individual treatment plan.
Ear Wax Removal ( Microsuction )
Earwax (cerumen) is a natural protective substance produced by ear glands to trap dirt and repel water. However, when earwax becomes impacted or builds up excessively, it can cause distressing symptoms including sudden hearing loss, ear fullness, dull ache, tinnitus (ringing or buzzing in the ears), itchiness, dizziness, and whistling hearing aids. Microsuction is the clinical gold-standard method for safe, gentle, and effective earwax removal, recommended by NICE guidelines over traditional water irrigation. Using an operating binocular loupe or surgical microscope for high-magnification direct illumination, our certified ear care practitioner uses a medical-grade suction wand to gently vacuum the wax from the ear canal without squirting water against the delicate eardrum. It is completely dry, significantly reduces infection risk, and is safe even for patients with previous perforated eardrums.
Travel Clinic Services
Altitude Sickness
Travelling to a high-altitude destination can increase your risk of altitude sickness, especially if you ascend quickly. During this consultation, a healthcare professional can review your itinerary, planned rate of ascent, medical history and any medicines you take. They can advise on gradual acclimatisation, symptoms to watch for and whether preventive medication is suitable for you. Medication is subject to an individual clinical assessment and availability. It does not replace gradual ascent. If you develop symptoms while travelling, do not continue ascending; seek medical advice. Severe symptoms require urgent descent and medical help.
Travellers' Diarrhoea Treatment
A clinical consultation for adults experiencing travellers' diarrhoea while travelling or shortly after travel. A qualified healthcare professional will assess your symptoms, medical history and current medicines to determine the appropriate treatment. The service is intended for uncomplicated travellers' diarrhoea and is subject to clinical assessment and eligibility criteria.
Antimalarials
Malaria is a life-threatening, mosquito-borne parasitic disease caused by Plasmodium parasites (predominantly Plasmodium falciparum and Plasmodium vivax) transmitted by nocturnal-biting female Anopheles mosquitoes in sub-Saharan Africa, South America, and Asia. Symptoms include cyclic high fever, rigors, profuse sweating, headache, vomiting, muscle pain, and without prompt treatment, severe anemia, cerebral malaria, organ failure, and death. Our travel clinic pharmacist performs an individualized risk assessment to recommend and prescribe the most appropriate antimalarial chemoprophylaxis under UK Health Security Agency (UKHSA) and NaTHNaC guidelines: - Atovaquone / Proguanil (Malarone): Daily tablet, started 1–2 days before travel, taken daily during travel, and continued for 7 days after leaving risk area. Minimal side effects. - Doxycycline: Daily antibiotic capsule, started 1–2 days before travel and continued for 4 weeks after return. - Mefloquine (Lariam): Weekly tablet started 3 weeks before departure and continued for 4 weeks post-return.
Hajj & Umrah Vaccination Package
Pilgrims undertaking Hajj or Umrah in Saudi Arabia face unique health risks due to intense physical exertion, crowded accommodations, and close proximity to millions of international pilgrims from over 180 countries. The Ministry of Health of the Kingdom of Saudi Arabia strictly mandates that all pilgrims arriving for Hajj or Umrah must produce valid proof of vaccination against Meningococcal Meningitis (ACWY) administered not less than 10 days and not more than 3 to 5 years prior to arrival. Our specialized Hajj & Umrah package provides: 1. ACWY Meningococcal conjugate vaccine (MenQuadfi or Nimenrix) 2. Official stamped Saudi-compliant Certificate of Vaccination 3. Seasonal Flu & COVID-19 booster check 4. Travel health advisory on respiratory hygiene ('Hajj cough'), heat exhaustion, blister care, and pilgrim travel first aid.
Travel Vaccination Service (Full Programme)
Comprehensive international travel health requires a personalized, destination-specific clinical risk assessment. Factors including exact geographical coordinates, duration, rural vs. urban accommodations, altitude, food hygiene standards, and planned activities (such as trekking, animal contact, or medical volunteer work) determine your clinical exposure risks. Our full Travel Vaccination Programme offers a complete clinical consultation where our travel health pharmacist reviews your entire itinerary against real-time global epidemiological databases (NaTHNaC / UKHSA / WHO). We design a customized, prioritized vaccination and prophylaxis plan covering Yellow Fever, Typhoid, Hepatitis A & B, Rabies, Meningitis ACWY, Tetanus/Diphtheria/Polio, Japanese Encephalitis, Cholera, and Antimalarials, and administer the required injections during your appointment.
Vaccination Services
Chickenpox Vaccine
Chickenpox (varicella) is a highly infectious viral illness caused by the varicella-zoster virus. It spreads through respiratory droplets or direct contact with blister fluid. Symptoms include an intensely itchy rash that develops into fluid-filled blisters, fever, loss of appetite, and headache. While often mild in young children, chickenpox can lead to serious complications including bacterial skin infections, scarring, pneumonia, and encephalitis, and is substantially more severe in adults, pregnant women, and newborns. The Chickenpox vaccine (Varivax or Varilrix) is a live-attenuated viral vaccine that provides 98% protection against severe disease in children and 75–85% protection against all infection. The course consists of two doses administered 4 to 8 weeks apart.
DTP Booster ( Diphtheria, Tetanus & Polio )
The 3-in-1 teenage booster (Revaxis) protects against three serious bacterial and viral diseases: - Diphtheria: A bacterial throat and respiratory infection that produces a toxin forming a thick gray pseudo-membrane, causing airway obstruction and heart failure. - Tetanus ('lockjaw'): Caused by Clostridium tetani spores found in soil and manure entering through wounds or burns, releasing a neurotoxin that triggers painful, uncontrollable muscle spasms. - Polio (poliomyelitis): A viral infection that attacks motor neurons in the spinal cord, leading to permanent paralysis and death. A booster dose every 10 years maintains protective antibody levels, especially for individuals travelling to regions where diphtheria or polio remain endemic or who sustain tetanus-prone injuries.
HPV Vaccine (Gardasil 9)
Human Papillomavirus (HPV) is a widespread sexually transmitted virus affecting both males and females. High-risk oncogenic HPV types (specifically 16, 18, 31, 33, 45, 52, and 58) are directly responsible for over 99% of cervical cancers, as well as significant proportions of anal, penile, throat (oropharyngeal), vaginal, and vulval cancers. Low-risk HPV types 6 and 11 cause approximately 90% of genital warts. Gardasil 9 is the 9-valent recombinant HPV vaccine providing the broadest coverage available against all 9 clinically important HPV strains. It protects both men and women against HPV-related cancers and genital warts. Dosing is 2 doses (aged 9–14) or 3 doses (aged 15+) at 0, 2, and 6 months.
MMR Vaccine ( Measles, Mumps & Rubella )
Measles, mumps, and rubella are highly infectious viral diseases capable of causing life-threatening complications: - Measles causes high fever, cough, conjunctivitis, and a full-body rash, and can lead to pneumonia, encephalitis, and subacute sclerosing panencephalitis. - Mumps causes painful swelling of the parotid salivary glands, fever, and can cause viral meningitis, orchitis (testicular inflammation), and hearing loss. - Rubella (German measles) can cause severe Congenital Rubella Syndrome (deafness, cataracts, cardiac defects) if caught by pregnant women. The MMR vaccine (Priorix or MMRVaxPro) is a safe, highly effective live-attenuated combined vaccine. Two doses provide 99% lifelong protection against measles and rubella, and 88% against mumps.
Meningitis ACWY Vaccine
Meningococcal disease is a life-threatening infection caused by Neisseria meningitidis bacteria that leads to meningitis (inflammation of the protective brain membranes) and septicemia (blood poisoning). The MenACWY conjugate vaccine protects against four major aggressive strains: A, C, W, and Y. Strain W is particularly virulent and can present with unusual gastrointestinal symptoms before rapid deterioration. Teenagers, university students living in halls, and international travellers (especially to the sub-Saharan African meningitis belt and pilgrims to Saudi Arabia) are at heightened risk of carriage and transmission. A single dose provides robust immunity lasting up to 5 years.
Meningitis B Vaccine
Meningococcal group B is the leading cause of bacterial meningitis and meningococcal septicemia in the UK, particularly in infants, young children, and adolescents. Meningitis B develops rapidly and can cause devastating consequences, including brain damage, hearing loss, limb amputations from gangrenous septicemia, and a 10% mortality rate. Bexsero is a multi-component recombinant vaccine specifically engineered to target Neisseria meningitidis group B. The vaccine stimulates antibodies against four specific surface antigens. For adolescents and adults, the schedule consists of two doses given at least one month apart.
Private Flu Vaccine
Influenza is an acute respiratory infection that causes fever, muscle aches, sore throat, severe fatigue, and productive cough. Even healthy adults can be incapacitated for a week or more, leading to missed work, lost productivity, and the risk of passing the virus to vulnerable family members. Our private flu vaccination service offers the latest quadrivalent seasonal influenza vaccine to any individual aged 18 and older (or children aged 2+) who does not meet the strict NHS eligibility criteria but wishes to protect themselves and their households. The vaccine contains four WHO-recommended inactivated viral strains and stimulates high protective antibody titers within 10 to 14 days.
Shingles Vaccine
Shingles is a painful, blistering rash caused by the reactivation of the chickenpox virus in sensory nerves. Post-herpetic neuralgia (PHN)—intense, debilitating nerve pain that can persist for months or years after the rash heals—is the most common and distressing complication, occurring in up to 30% of older adults who develop shingles. Shingrix is a state-of-the-art non-live, recombinant subunit adjuvanted vaccine that provides greater than 90% protection against shingles and PHN across all adult age groups, with efficacy remaining high for at least 10 years. Unlike older live shingles vaccines, Shingrix cannot cause disease and is safe for immunocompromised individuals. A full course consists of two intramuscular doses given 2 to 6 months apart.
Weight Management
Orlistat Capsules (Private Supply)
Orlistat 120mg is an MHRA-licensed, prescription-strength lipase inhibitor medication designed for medical weight management. Unlike injectable GLP-1 medications that act on the brain's appetite centers, orlistat works locally in the gastrointestinal tract. Orlistat binds to gastric and pancreatic lipases, preventing these digestive enzymes from breaking down dietary fats into absorbable fatty acids. As a result, approximately one-third (30%) of the fat consumed in meals passes through the intestines unabsorbed and is eliminated naturally in bowel movements. Clinical studies show that orlistat combined with a reduced-calorie, low-fat diet helps patients achieve significantly greater weight loss than diet alone.
Wegovy (Semaglutide) Supply & Monitoring
Wegovy (semaglutide) is an MHRA-licensed, prescription-only glucagon-like peptide-1 (GLP-1) receptor agonist recommended by NICE (technology appraisal guidance TA875) for chronic weight management alongside a reduced-calorie diet and increased physical activity. Semaglutide mimics the natural GLP-1 fullness hormone released in the gut after eating. It acts on appetite centers in the brain to reduce hunger, increase satiety, curb cravings, and slow gastric emptying, helping patients achieve meaningful, sustainable weight loss (averaging 15% body weight reduction in clinical trials). Our clinical weight management service includes a full medical consultation, baseline BMI and blood pressure assessment, prescription supply of the pre-filled Wegovy FlexTouch pen, injection technique coaching, structured monthly dose titration (0.25mg up to 2.4mg maintenance), and continuous monitoring for side effects and clinical progress.
Weight Management Consultation (Private)
Losing weight and keeping it off is a complex biological challenge that requires medical expertise, personalized strategies, and ongoing empathetic support. Our comprehensive Private Weight Management Consultation provides a confidential 30-minute session with an accredited prescribing pharmacist. We evaluate your medical history, dietary patterns, previous attempts, emotional eating triggers, and lifestyle factors. We perform biometric screening (BMI, blood pressure, waist-to-hip ratio) and discuss the full spectrum of evidence-based options—including prescription GLP-1/GIP treatments (Wegovy, Mounjaro), oral lipase inhibitors (Orlistat), and realistic nutritional and exercise adjustments tailored to your routine.
BMI & Blood Pressure Assessment (Weight Clinic)
Accurate baseline physical measurements are the essential clinical foundation for any safe, effective weight management plan. Carrying excess weight significantly impacts cardiovascular workload and metabolic markers. During this dedicated consultation in our private clinic room, our clinical pharmacist measures your exact height, weight, waist circumference, Body Mass Index (BMI), resting heart rate, and blood pressure using calibrated, medical-grade equipment. We review your cardiovascular risk score, discuss your weight goals, and identify which clinical treatments (such as GLP-1 injections or oral therapies) or lifestyle programmes you safely qualify for under NICE guidelines.
Mounjaro KwikPen (Tirzepatide) Supply & Monitoring
Mounjaro (tirzepatide) is a breakthrough first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist licensed by the MHRA and recommended by NICE (technology appraisal TA1003) for chronic weight management. By simultaneously activating both GIP and GLP-1 receptors, tirzepatide synergistically regulates appetite, reduces food intake, improves insulin sensitivity, and curbs food cravings more effectively than single-receptor agonists, delivering average weight reductions of up to 20–22% in clinical trials. Our private weight clinic provides comprehensive clinical onboarding, baseline metabolic health screening, supply of the multi-dose Mounjaro KwikPen, personalized step-wise dose titration (2.5mg up to 15mg), injection training, and monthly reviews to monitor progress and maintain lean muscle mass.
Women's Health Services
Period delay tablets
The Period Delay Tablets service provides a clinical assessment for people who want to temporarily delay an upcoming menstrual period, for example for a holiday, travel, special event or other planned occasion. A healthcare professional will assess your medical history, menstrual cycle, current medicines and suitability for treatment. Where clinically appropriate, a prescription for norethisterone may be provided. Norethisterone is licensed in the UK for postponement of menstruation. It is not a contraceptive, so appropriate contraception should still be used where pregnancy prevention is required.
NHS Services
NHS Free Blood Pressure Check
NHS-commissioned hypertension case-finding check, based on NICE guidance (NG136), to spot undiagnosed high blood pressure before it leads to stroke or heart attack. Provided opportunistically to walk-in adults or by GP referral; raised readings are followed up with ambulatory monitoring and a GP referral.
NHS COVID-19 Vaccination Service
NHS-funded COVID-19 booster that maintains protection against severe illness and hospitalisation, delivered under the national COVID-19 vaccination programme. Offered to the cohorts eligible that season (e.g. 65+, care home residents, immunosuppressed, health and social care workers) as set by JCVI guidance.
NHS Contraception Service
NHS Pharmacy Contraception Service: ongoing supply and initiation of oral contraception, plus supply of oral emergency contraception, via a Patient Group Direction (PGD). Open to anyone needing contraception (no GP registration required); safeguarding processes apply for under-16s; all supplies are free of charge.
Men's Health Services
Hair Loss Treatment (Private)
Male androgenetic alopecia (male pattern baldness) is the most common cause of progressive hair thinning and hair loss in men, affecting up to 50% of men by age 50. It is driven by genetic sensitivity of hair follicles to dihydrotestosterone (DHT), a potent androgen derived from testosterone via the 5-alpha reductase enzyme. Over time, DHT causes miniaturization of hair follicles on the crown and temples, resulting in thinner, shorter hairs and eventual follicular dormancy. Our private hair loss clinic provides clinical assessment and supply of evidence-based medical treatments that stop progression and stimulate regrowth: 1. Oral Finasteride 1mg (Propecia / generic): A selective type II 5-alpha reductase inhibitor that reduces scalp DHT levels by up to 70%, halting hair loss in over 85% of men and stimulating visible regrowth in two-thirds. 2. Topical Minoxidil (5% solution or foam): A vasodilator that enhances microcirculation around follicles, extending the anagen (growth) phase of hair. 3. Combined dual-action therapies for maximum hair preservation.
Private Blood Pressure Check
Regular cardiovascular monitoring is one of the most effective preventative health habits. High blood pressure puts extra strain on your heart and blood vessels, often without producing any noticeable symptoms until damage has occurred. Our Private Blood Pressure Check is designed for individuals who are not eligible under the free NHS scheme (such as adults under 40 without a referral or those seeking regular private monitoring). Conducted in a quiet, confidential consultation room using certified electronic oscillometric monitors, the appointment includes dual readings, pulse check, and actionable advice on nutrition, sodium reduction, stress management, and exercise.
Pharmacy First
Acute Sinusitis
Pharmacy First clinical pathway: assessment and treatment of acute sinusitis, including antibiotics only where red flags are absent and symptoms meet the clinical criteria. Available to patients aged 12 years and over, under the national clinical pathway.
Acute Sore Throat
Pharmacy First clinical pathway: assessment for acute sore throat using a validated scoring tool, with antibiotics supplied only where clinically indicated. Available to patients aged 5 years and over, following the national clinical pathway and safety-netting advice.
Earache
Pharmacy First clinical pathway: assessment and, where appropriate, antibiotic treatment for acute otitis media (earache) in children. Available to patients aged 1–17 years; note that distance-selling (online-only) pharmacies cannot provide this pathway.
Impetigo
Pharmacy First clinical pathway: assessment and antibiotic treatment for impetigo, a contagious bacterial skin infection. Available to patients aged 1 year and over, under the national clinical pathway.
Infected Insect Bite
Pharmacy First clinical pathway: assessment and, where indicated, antibiotic treatment for an infected insect bite to stop it worsening or spreading. Available to patients aged 1 year and over, under the national clinical pathway.
Shingles
Pharmacy First clinical pathway: assessment and antiviral treatment to reduce the severity and duration of shingles and lower the risk of complications. Available to patients aged 18 years and over, under the national clinical pathway.
Urinary Tract Infections (UTI) (Women 16–64)
Pharmacy First clinical pathway: pharmacist assessment and, where appropriate, antibiotic supply for an uncomplicated urinary tract infection, following the national clinical pathway and PGD. Restricted to women aged 16–64 years; men, pregnant women, children, and women over 64 must be referred on (e.g. to a GP) rather than treated under this pathway.